1. Home
  2. JOUT vs PGEN Comparison

JOUT vs PGEN Comparison

Compare JOUT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$48.94

Market Cap

486.7M

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
PGEN
Founded
1970
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
486.7M
1.4B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
JOUT
PGEN
Price
$48.94
$4.12
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.33
AVG Volume (30 Days)
59.4K
5.1M
Earning Date
05-01-2026
05-13-2026
Dividend Yield
2.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$592,415,000.00
$230,981,000.00
Revenue This Year
$11.67
$1,115.92
Revenue Next Year
$3.70
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.33
$1.12
52 Week High
$51.66
$5.47

Technical Indicators

Market Signals
Indicator
JOUT
PGEN
Relative Strength Index (RSI) 62.76 57.79
Support Level $42.67 $4.02
Resistance Level $51.34 $4.44
Average True Range (ATR) 1.93 0.31
MACD 0.43 0.12
Stochastic Oscillator 98.11 87.04

Price Performance

Historical Comparison
JOUT
PGEN

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: